InvestorsHub Logo
Followers 67
Posts 826
Boards Moderated 0
Alias Born 03/19/2009

Re: None

Wednesday, 09/01/2010 3:15:31 PM

Wednesday, September 01, 2010 3:15:31 PM

Post# of 10804
VODG(.15)...stem cell-derived food.....

The two announced business relationships that VODG has attracted in the last 4 months or so are pretty interesting, IMO.

With the addition of an investment banker to VODG's Board of Directors, and the CEO's mention in his May 18 shareholder letter that the strategic alliance VODG and HemoGenix have formed "may lead to an appropriate business combination", I think the possibility of some merger/acquisition activity involving VODG has significantly increased.

The contract with Mokshagundam Biotechnologies expands the use of VODG's products/technologies beyond just the medical arena. VODG's cell culture media and cellular immortalization technology could ultimately find its way into the commercial production of stem cell-derived meat for consumption by animals/humans.....

Dr. Jim Musick, Vitro’s CEO said, “We are pleased to be involved with this ground breaking opportunity to extend stem cell technology to development of alternative food sources. Cellular immortality as reflected in continual stem cell proliferation (self-renewal) has potential to provide limitless cells that when differentiated to muscle, for example, become the primary ingredient of meat. This reflects the basis of alternative food derived from stem cells that is now being developed. We intend to use our expertise in stem cell media development and commercial manufacture to provide appropriate media formulations to support this nascent technology. Our VITROGROW™ Brand of stem cell media has been demonstrated to result in superior performance to competing products in the growth of human adult stem cells and is now utilized in high performance, bioluminescent test kits (Lumenesc-Hu™ and LumiSTEM™) for measuring the quality and potency of mesenchymal and induced-pluripotent stem cells. We anticipate contributing to this exciting new field and plan to further develop cellular immortalization procedures that may be crucial to economic production of stem cell-derived meat.”

http://www.vitrobiopharma.com/investorrelations/press22.html

This is a link to Kedar Challakere's (Mokshagundam Biotechnologies) patent application......

http://www.wipo.int/pctdb/en/wo.jsp?WO=2010068897&IA=US2009067721&DISPLAY=DESC


Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.